It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalised with pneumonia due to covid-19, finds a study from France published by The BMJ today.
A randomised clinical trial from China also published today shows that hospitalised patients with mild to moderate persistent covid-19 who received hydroxychloroquine did not clear the virus more quickly than those receiving standard care. Adverse events were higher in those who received hydroxychloroquine.
Taken together, the results do not support routine use of hydroxychloroquine for patients with covid-19.
Sermo is a private social media network for physicians open to licensed M.D.s and D.O.s in the United States, and 149 other countries across Europe, North and South America, Africa, and English-speaking Oceania. Wikipedia
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context April 2, 2020 Sermo Reports on Hydroxychloroquine Efficacy, Rise in Prophylaxis Use; Over 80% Expect 2nd Outbreak New York, New York – April 2, 2020 – Widespread confusion, conflicting reports, inconsistent testing, and off-indication use of existing and experimental drugs has resulted in no single source of information from the frontlines. To create a centralized and dynamic knowledge base, Sermo, the largest healthcare data collection company and global social platform for physicians, leveraged its capabilities to publish results of a COVID-19 study with more than 6,200 physicians in 30 countries. The study was completed in three days. Data covers current treatment and prophylaxis options, timing to the outbreak peak, effectiveness of government responses, and much more. Results of the first wave can be found at sermo.com. Multiple study waves including a deeper dive into treatments will be conducted over the next several weeks, and Sermo is calling all physicians globally to participate. Key findings; Sermo Real Time Barometer*:
Qatar launches world's toughest punishments with three years in jail and £45,000 fines for anyone not wearing a face mask as it battles one of globe's highest coronavirus infection rates
originally posted by: Waterglass
a reply to: Agit8dChop
Go to Servo!!!
Servo
You mean Sermo? Ok.
Go to Servo!!!
originally posted by: Waterglass
a reply to: Byrd
Take a look at this.
NO MSM
NO NWO
NO WHO
NO TRUMP
It the closest web site dealing with the truth that I have found to date:
Servo
Studies have shown that deficiency in LL-37 in humans leads to an increased susceptibility to infection [73], and mice deficient in the murine cathelicidin (mCRAMP) also display an increased susceptibility to both bacterial and viral infections of the airway tract, skin, urinary tract and gut [74,75,76]. On the contrary, exogenous delivery of LL-37 in murine models offered enhanced clearance and reduced mortality in lethal influenza infection [77].
Cathelicidins have shown potent antiviral activity against a number of viruses (reviewed in [70]) but the exact mechanism of action is still not fully elucidated. It is clear that the underlying antiviral mechanism of cathelicidins appears to be partly due to direct effects on the virus envelope, and this has been extensively shown in in vitro studies. Both LL-37, and the murine cathelicidin mCRAMP, have shown the ability to damage the viral envelope of vaccinia virus, influenza A virus (IAV) and HSV [77,78,79,80]. LL-37 has also been shown to target viral envelope proteins inhibiting dengue virus entry into host cells [81].
Cathelicidin peptides have been isolated from many different species of mammals. Cathelicidins were originally found in neutrophils, but have since been found in many other cells including epithelial cells and macrophages after activation by bacteria, viruses, fungi, or the hormone 1,25-D, which is the hormonally active form of vitamin D.[7]
originally posted by: deccal
a reply to: Byrd
Is vitamin D good or bad? Should we take it in order to protect us or the opposite? Could you please elaborate? Thanks
Its called Stockholm syndrome
originally posted by: anonentity
a reply to: McGinty
Its called Stockholm syndrome, A small little Island with to many people per square mile.
Please indicate which medications you are currently using to treat COVID-19 patients In the hospital (moderate-severe symptoms, excluding ICU patients).
Hydroxychloroquine (Plaquenil) or Chloroquine
56%
Azithromycin or similar antibiotics
54%
Tocilizumab (Actemra)
30%
Remdesivir
26%
Anti-HIV drugs (e.g. Lopinavir plus Ritonavir – Kaletra)
23%
Plasma from patients who have recovered from COVID-19 (convalescent plasma)
17%
Oseltamivir (Tamiflu)
12%
Zinc
11%
Gamma Globulin
9%
Favipiravir (Avigan)
8%
Acyclovir
8%
Interferon-beta
7%
Colchicine
6%
Ivermectin
5%
Sarilumab (Kevzara)
4%
Traditional Chinese Medicine
4%
Methotrexate
3%
N